Dr. Tom Van Der Hulle
Clinical trials sponsored by Dr. Tom Van Der Hulle, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Skipping doses could cut cancer drug costs without losing effect Results expected Sep 2027 (estimated)